Dr. Vivek Dwivedi

Nanotherapeutics or Nanomedicines can improve drug solubility by providing hydrophilic and hydrophobic environments, protect the payload from premature degradation by functioning as a sustained release systems thereby reducing dosing frequencies, control the rate of drug release. Plenty of micro/nano based formulations have been reported so far in metabolic disorders and many have gone into clinical trials.
some of the significant formulations are Conjugates, Micelles, Dendrimer, Lipid nanosuspension, Nanostructured lipid carrier, Solid Lipid Nanoparticles, Liposomes.